1 |
Mota MTO, Costa VV, Sugimoto MA, Guimarães GF, Queiroz-Junior CM, Moreira TP, de Sousa CD, Santos FM, Queiroz VF, Passos I, Hubner J, Souza DG, Weaver SC, Teixeira MM, Nogueira ML. In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease. Sci Rep 2020;10:5306. [PMID: 32210270 DOI: 10.1038/s41598-020-62084-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
2 |
Diagne CT, Bengue M, Choumet V, Hamel R, Pompon J, Missé D. Mayaro Virus Pathogenesis and Transmission Mechanisms. Pathogens 2020;9:E738. [PMID: 32911824 DOI: 10.3390/pathogens9090738] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
|
3 |
Bengue M, Pintong AR, Liegeois F, Nougairède A, Hamel R, Pompon J, de Lamballerie X, Roques P, Choumet V, Missé D. Favipiravir Inhibits Mayaro Virus Infection in Mice. Viruses 2021;13:2213. [PMID: 34835018 DOI: 10.3390/v13112213] [Reference Citation Analysis]
|
4 |
Ferraz AC, Almeida LT, da Silva Caetano CC, da Silva Menegatto MB, Souza Lima RL, de Senna JPN, de Oliveira Cardoso JM, Perucci LO, Talvani A, Geraldo de Lima W, de Mello Silva B, Barbosa Reis A, de Magalhães JC, Lopes de Brito Magalhães C. Hepatoprotective, antioxidant, anti-inflammatory, and antiviral activities of silymarin against mayaro virus infection. Antiviral Res 2021;194:105168. [PMID: 34437912 DOI: 10.1016/j.antiviral.2021.105168] [Reference Citation Analysis]
|